Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Presymptomatic testing for Huntington's disease.

|June 14, 1985

Summary

This summary is machine-generated.

A DNA marker for Huntington's disease (HD) is now available, enabling presymptomatic testing. Responsible development requires careful consideration of ethical issues and robust support systems for individuals at risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Supplemental peri-operative intravenous crystalloids for postoperative nausea and vomiting: an abridged Cochrane systematic review.

Anaesthesia·2019

Same author

Encephalopathy and peripheral neuropathy following diethylene glycol ingestion.

Neurology·2005

Same author

Clinical neurophysiology in the intensive care unit.

Supplements to Clinical neurophysiology·2003

Same author

Mentoring and the responsible conduct of research: reflections and future.

Science and engineering ethics·2001

Same author

Mentors, advisors and supervisors: their role in teaching responsible research conduct.

Science and engineering ethics·2001

Same author

Scientific certainty: research versus forensic perspectives.

Journal of forensic sciences·2001

Same journal

WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

JAMA·2026

Same journal

FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

JAMA·2026

Same journal

HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

JAMA·2026

Same journal

US Dietary Supplement Use Increasing, Especially in Older Adults.

JAMA·2026

Same journal

Heat Stress From Climate Change Surges Globally.

JAMA·2026

Same journal

Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

JAMA·2026

See all related articles

Area of Science:

Genetics
Neurology
Biotechnology

Background:

Recombinant DNA technology has enabled the identification of a DNA marker for Huntington's disease (HD).
Huntington's disease is a progressive neurodegenerative disorder.
There is a growing need for diagnostic tools for inherited neurological conditions.

Purpose of the Study:

To discuss the implications of a DNA marker for Huntington's disease.
To explore the feasibility and ethical considerations of presymptomatic testing for HD.
To outline the necessary support structures for individuals undergoing HD testing.

Main Methods:

Identification of a DNA marker using recombinant DNA technology.
Review of ethical, policy, and societal concerns related to genetic testing.

Keywords:

Genetics and Reproduction

Related Experiment Videos

Analysis of support systems required for presymptomatic testing.

Main Results:

A DNA marker for Huntington's disease has been identified.
Presymptomatic testing for HD is likely to become available.
Ethical and policy concerns necessitate careful consideration.

Conclusions:

Presymptomatic testing for Huntington's disease should be offered with safeguards for confidentiality.
A multidisciplinary approach involving healthcare professionals, researchers, and patient organizations is crucial.
Supportive settings are essential for autonomous decision-making regarding HD testing.